01.21.26 -- ARM's Tim Hunt On Expanding Patient Access, Smarter Regulation, And A More Sustainable Market In 2026

Master MSC characterization and uncover the therapeutic potential of diverse tissue sources. Optimize your laboratory workflows by aligning cell biology with scalable manufacturing technologies.

Gain insight into how to choose and validate normalization strategies for western blots, avoid common pitfalls, and ensure reproducible results using proteins tailored to your experimental context.

By integrating AI and mechanistic models into early design, developers can overcome traditional biomanufacturing productivity limits and accelerate timelines for complex therapeutic modalities.

From donor variability to collection site inconsistencies, cell and gene therapy faces raw material challenges. Ensuring stable, high-quality leukopaks is vital for effective treatments.

Whether you are new to Organ-on-a-Chip technology or seeking to expand your expertise, watch to gain the knowledge and insights needed to effectively implement this technology into your research.

AI-driven spatial proteomics in 4T1 murine tumors reveals diverse immune populations, and pro-tumorigenic environments, advancing insights into tumor progression and therapeutic resistance.

Non-viral gene editing is a powerful method for cell therapy. Examine key challenges like cell viability and thermal damage with an innovative approach designed to improve performance.

Optimize cell culture for solid tumor research. Replacing traditional serum can significantly enhance CAR-T cytotoxicity, improve consistency, and streamline the path to GMP-ready workflows.